nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.112	0.115	CbGeAlD
Yohimbine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0607	0.0622	CbGeAlD
Yohimbine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0588	0.0602	CbGeAlD
Yohimbine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0292	0.0299	CbGeAlD
Yohimbine—HTR2A—pons—amyotrophic lateral sclerosis	0.0289	0.0296	CbGeAlD
Yohimbine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0246	0.0252	CbGeAlD
Yohimbine—DRD2—nerve—amyotrophic lateral sclerosis	0.0227	0.0232	CbGeAlD
Yohimbine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0226	0.0231	CbGeAlD
Yohimbine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.0212	0.0217	CbGeAlD
Yohimbine—HTR2A—appendage—amyotrophic lateral sclerosis	0.0211	0.0216	CbGeAlD
Yohimbine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0192	0.0197	CbGeAlD
Yohimbine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.0188	0.0193	CbGeAlD
Yohimbine—HTR1F—nervous system—amyotrophic lateral sclerosis	0.0171	0.0175	CbGeAlD
Yohimbine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.017	0.0174	CbGeAlD
Yohimbine—HTR1F—central nervous system—amyotrophic lateral sclerosis	0.0164	0.0168	CbGeAlD
Yohimbine—HTR2A—nerve—amyotrophic lateral sclerosis	0.015	0.0153	CbGeAlD
Yohimbine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.0134	0.0137	CbGeAlD
Yohimbine—HTR1F—brain—amyotrophic lateral sclerosis	0.0131	0.0134	CbGeAlD
Yohimbine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.0129	0.0132	CbGeAlD
Yohimbine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.0128	0.0131	CbGeAlD
Yohimbine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.0121	0.0124	CbGeAlD
Yohimbine—DRD3—nervous system—amyotrophic lateral sclerosis	0.0121	0.0124	CbGeAlD
Yohimbine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.0116	0.0119	CbGeAlD
Yohimbine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.0112	0.0115	CbGeAlD
Yohimbine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.0108	0.011	CbGeAlD
Yohimbine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.0102	0.0105	CbGeAlD
Yohimbine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00974	0.00998	CbGeAlD
Yohimbine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00927	0.00949	CbGeAlD
Yohimbine—DRD3—brain—amyotrophic lateral sclerosis	0.00922	0.00944	CbGeAlD
Yohimbine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00906	0.00928	CbGeAlD
Yohimbine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00893	0.00915	CbGeAlD
Yohimbine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00892	0.00914	CbGeAlD
Yohimbine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00873	0.00894	CbGeAlD
Yohimbine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00831	0.00851	CbGeAlD
Yohimbine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00796	0.00816	CbGeAlD
Yohimbine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00755	0.00773	CbGeAlD
Yohimbine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00708	0.00726	CbGeAlD
Yohimbine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00701	0.00718	CbGeAlD
Yohimbine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.007	0.00717	CbGeAlD
Yohimbine—ADRA1D—brain—amyotrophic lateral sclerosis	0.00693	0.0071	CbGeAlD
Yohimbine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00678	0.00694	CbGeAlD
Yohimbine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00674	0.0069	CbGeAlD
Yohimbine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00671	0.00687	CbGeAlD
Yohimbine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.0067	0.00687	CbGeAlD
Yohimbine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.0066	0.00676	CbGeAlD
Yohimbine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00652	0.00668	CbGeAlD
Yohimbine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00646	0.00662	CbGeAlD
Yohimbine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00642	0.00658	CbGeAlD
Yohimbine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00636	0.00652	CbGeAlD
Yohimbine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.0063	0.00646	CbGeAlD
Yohimbine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00612	0.00627	CbGeAlD
Yohimbine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00607	0.00622	CbGeAlD
Yohimbine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00589	0.00603	CbGeAlD
Yohimbine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00585	0.00599	CbGeAlD
Yohimbine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00565	0.00578	CbGeAlD
Yohimbine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00544	0.00557	CbGeAlD
Yohimbine—HTR1B—brain—amyotrophic lateral sclerosis	0.00535	0.00548	CbGeAlD
Yohimbine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00531	0.00544	CbGeAlD
Yohimbine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00527	0.0054	CbGeAlD
Yohimbine—HTR1D—brain—amyotrophic lateral sclerosis	0.00518	0.0053	CbGeAlD
Yohimbine—HTR2C—brain—amyotrophic lateral sclerosis	0.00513	0.00525	CbGeAlD
Yohimbine—DRD2—nervous system—amyotrophic lateral sclerosis	0.0051	0.00523	CbGeAlD
Yohimbine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00496	0.00508	CbGeAlD
Yohimbine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00491	0.00503	CbGeAlD
Yohimbine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00486	0.00498	CbGeAlD
Yohimbine—HTR2B—brain—amyotrophic lateral sclerosis	0.00482	0.00493	CbGeAlD
Yohimbine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.0048	0.00492	CbGeAlD
Yohimbine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00478	0.00489	CbGeAlD
Yohimbine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.0047	0.00481	CbGeAlD
Yohimbine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00467	0.00478	CbGeAlD
Yohimbine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00448	0.00459	CbGeAlD
Yohimbine—HTR1A—brain—amyotrophic lateral sclerosis	0.00432	0.00442	CbGeAlD
Yohimbine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00399	0.00409	CbGeAlD
Yohimbine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00396	0.00405	CbGeAlD
Yohimbine—DRD2—brain—amyotrophic lateral sclerosis	0.0039	0.004	CbGeAlD
Yohimbine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00381	0.0039	CbGeAlD
Yohimbine—ADRA2C—brain—amyotrophic lateral sclerosis	0.00379	0.00388	CbGeAlD
Yohimbine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00372	0.00382	CbGeAlD
Yohimbine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00337	0.00345	CbGeAlD
Yohimbine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00324	0.00332	CbGeAlD
Yohimbine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00317	0.00324	CbGeAlD
Yohimbine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00312	0.00319	CbGeAlD
Yohimbine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00307	0.00314	CbGeAlD
Yohimbine—ADRA2A—brain—amyotrophic lateral sclerosis	0.00303	0.0031	CbGeAlD
Yohimbine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.003	0.00307	CbGeAlD
Yohimbine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00295	0.00302	CbGeAlD
Yohimbine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00289	0.00296	CbGeAlD
Yohimbine—HTR2A—brain—amyotrophic lateral sclerosis	0.00257	0.00264	CbGeAlD
Yohimbine—CYP2D6—brain—amyotrophic lateral sclerosis	0.00234	0.0024	CbGeAlD
Yohimbine—HTR2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.88e-05	0.00079	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.87e-05	0.000787	CbGpPWpGaD
Yohimbine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.86e-05	0.000784	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.86e-05	0.000782	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.85e-05	0.000778	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.84e-05	0.000775	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.83e-05	0.000771	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.83e-05	0.000769	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.82e-05	0.000766	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.82e-05	0.000766	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.82e-05	0.000765	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.81e-05	0.000762	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.81e-05	0.000762	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.81e-05	0.000761	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.8e-05	0.000757	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	1.77e-05	0.000747	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.76e-05	0.000742	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.76e-05	0.000742	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.74e-05	0.000734	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.74e-05	0.000732	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.73e-05	0.000727	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.72e-05	0.000724	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.7e-05	0.000717	CbGpPWpGaD
Yohimbine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.7e-05	0.000714	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.69e-05	0.000711	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.68e-05	0.000705	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.66e-05	0.000701	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.66e-05	0.000698	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.65e-05	0.000694	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.000688	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.63e-05	0.000686	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.63e-05	0.000686	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.61e-05	0.000677	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.6e-05	0.000674	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.6e-05	0.000674	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.6e-05	0.000673	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.6e-05	0.000672	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.59e-05	0.00067	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.58e-05	0.000664	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000661	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.55e-05	0.000654	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.55e-05	0.000651	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.54e-05	0.000646	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.53e-05	0.000643	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000643	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.53e-05	0.000642	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.52e-05	0.00064	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.5e-05	0.000633	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.5e-05	0.000632	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.5e-05	0.000631	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.49e-05	0.000626	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.49e-05	0.000626	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.49e-05	0.000626	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.48e-05	0.000624	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.47e-05	0.000618	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.46e-05	0.000616	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.45e-05	0.000613	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.44e-05	0.000608	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.43e-05	0.000601	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.41e-05	0.000593	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.4e-05	0.000587	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.4e-05	0.000587	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.39e-05	0.000587	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.39e-05	0.000584	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000583	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.000574	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.35e-05	0.000568	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.35e-05	0.000568	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.34e-05	0.000565	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.33e-05	0.00056	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.33e-05	0.000559	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.33e-05	0.000559	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.33e-05	0.000559	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.33e-05	0.000559	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.33e-05	0.000558	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.32e-05	0.000554	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.3e-05	0.000548	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.3e-05	0.000546	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.29e-05	0.000543	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.26e-05	0.000532	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.26e-05	0.00053	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.25e-05	0.000528	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000526	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000522	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.23e-05	0.00052	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.22e-05	0.000515	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000515	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.22e-05	0.000515	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.22e-05	0.000512	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.21e-05	0.000509	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.21e-05	0.000508	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.2e-05	0.000507	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.2e-05	0.000505	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.18e-05	0.000497	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.18e-05	0.000495	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	0.000494	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.16e-05	0.000488	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.16e-05	0.000488	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.16e-05	0.000487	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.15e-05	0.000485	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000484	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.14e-05	0.000479	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.14e-05	0.000479	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.14e-05	0.000479	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.12e-05	0.000472	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.12e-05	0.000472	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.1e-05	0.000465	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.1e-05	0.000464	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.1e-05	0.000461	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.08e-05	0.000455	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.000454	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.00045	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.00045	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.07e-05	0.00045	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.05e-05	0.000442	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000433	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.03e-05	0.000432	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.02e-05	0.000431	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.02e-05	0.000429	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.02e-05	0.000428	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.02e-05	0.000428	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000424	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1e-05	0.000421	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.97e-06	0.00042	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.91e-06	0.000417	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.86e-06	0.000415	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.66e-06	0.000407	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.66e-06	0.000406	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	9.6e-06	0.000404	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.59e-06	0.000404	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.56e-06	0.000402	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	9.56e-06	0.000402	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.53e-06	0.000401	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.46e-06	0.000398	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.45e-06	0.000398	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.45e-06	0.000398	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.44e-06	0.000397	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.32e-06	0.000392	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.27e-06	0.00039	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.2e-06	0.000387	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.1e-06	0.000383	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.02e-06	0.00038	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	8.93e-06	0.000376	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.88e-06	0.000374	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	8.87e-06	0.000374	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.8e-06	0.00037	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.8e-06	0.00037	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.76e-06	0.000369	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.7e-06	0.000366	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.68e-06	0.000365	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.56e-06	0.000361	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.53e-06	0.000359	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.5e-06	0.000358	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.32e-06	0.00035	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.24e-06	0.000347	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.19e-06	0.000345	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.18e-06	0.000345	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.05e-06	0.000339	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.97e-06	0.000336	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.94e-06	0.000334	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.84e-06	0.00033	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.81e-06	0.000329	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.79e-06	0.000328	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.67e-06	0.000323	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.63e-06	0.000321	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.56e-06	0.000318	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.42e-06	0.000312	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.33e-06	0.000308	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.3e-06	0.000307	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.27e-06	0.000306	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.27e-06	0.000306	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	7.25e-06	0.000305	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.23e-06	0.000304	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	7.21e-06	0.000303	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.12e-06	0.0003	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.73e-06	0.000283	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.62e-06	0.000279	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.56e-06	0.000276	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.56e-06	0.000276	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.54e-06	0.000275	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.47e-06	0.000273	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.4e-06	0.00027	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.34e-06	0.000267	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.3e-06	0.000265	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.21e-06	0.000262	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.18e-06	0.00026	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.13e-06	0.000258	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.08e-06	0.000256	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.05e-06	0.000255	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.03e-06	0.000254	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.03e-06	0.000254	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.01e-06	0.000253	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.71e-06	0.00024	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.68e-06	0.000239	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.6e-06	0.000236	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.6e-06	0.000236	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.56e-06	0.000234	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.55e-06	0.000234	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.47e-06	0.00023	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.43e-06	0.000229	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.29e-06	0.000223	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.29e-06	0.000223	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.1e-06	0.000215	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.05e-06	0.000213	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.98e-06	0.00021	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.94e-06	0.000208	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.88e-06	0.000205	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.85e-06	0.000204	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.77e-06	0.000201	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.75e-06	0.0002	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.75e-06	0.0002	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.72e-06	0.000199	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.7e-06	0.000198	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.65e-06	0.000196	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.61e-06	0.000194	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.59e-06	0.000193	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.46e-06	0.000188	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.39e-06	0.000185	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.29e-06	0.000181	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.28e-06	0.00018	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.21e-06	0.000177	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.19e-06	0.000177	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.14e-06	0.000174	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.12e-06	0.000173	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.11e-06	0.000173	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.06e-06	0.000171	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.05e-06	0.00017	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.01e-06	0.000169	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.98e-06	0.000168	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.94e-06	0.000166	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.86e-06	0.000162	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.83e-06	0.000161	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.73e-06	0.000157	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.63e-06	0.000153	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.62e-06	0.000153	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.59e-06	0.000151	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.59e-06	0.000151	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.58e-06	0.000151	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.25e-06	0.000137	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.24e-06	0.000136	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.22e-06	0.000135	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.13e-06	0.000132	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.11e-06	0.000131	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.07e-06	0.000129	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.03e-06	0.000127	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.98e-06	0.000125	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.75e-06	0.000116	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.7e-06	0.000114	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.46e-06	0.000103	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.1e-06	8.86e-05	CbGpPWpGaD
